Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the <i>Pseudomonas aeruginosa</i> Pathogenesis

Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the <i>Pseudomonas aeruginosa</i> Pathogenesis

Bacteria communicate with each other using quorum sensing (QS) which works in an inducer/receptor manner. QS plays the main role in orchestrating diverse bacterial virulence factors. <i>Pseudomonas aeruginosa</i> is one of the most clinically important bacterial pathogens that can cause...

Full description

Bibliographic Details
Main Authors:	Maan T. Khayat, Tarek S. Ibrahim, Khaled M. Darwish, Ahdab N. Khayyat, Majed Alharbi, El-Sayed Khafagy, Mohamed A. M. Ali, Wael A. H. Hegazy, Hisham A. Abbas
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Microorganisms
Subjects:	<i>Pseudomonas aeruginosa</i> linagliptin quorum sensing antimicrobial resistance bacterial virulence drug repurposing
Online Access:	https://www.mdpi.com/2076-2607/10/12/2455

Similar Items

Anti-Quorum Sensing Activities of Gliptins against <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i>
by: Maan T. Khayat, et al.
Published: (2022-05-01)

Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against <i>Pseudomonas aeruginosa</i> via Controlling Quorum Sensing Systems
by: Maan T. Khayat, et al.
Published: (2023-05-01)

The Anti-Virulence Activities of the Antihypertensive Drug Propranolol in Light of Its Anti-Quorum Sensing Effects against <i>Pseudomonas aeruginosa</i> and <i>Serratia marcescens</i>
by: Hadil Faris Alotaibi, et al.
Published: (2023-11-01)

Repurposing Anti-diabetic Drugs to Cripple Quorum Sensing in <i>Pseudomonas aeruginosa</i>
by: Wael A. H. Hegazy, et al.
Published: (2020-08-01)

Xylitol Inhibits Growth and Blocks Virulence in <i>Serratia marcescens</i>
by: Ahdab N. Khayyat, et al.
Published: (2021-05-01)

Sodium Citrate Alleviates Virulence in <i>Pseudomonas aeruginosa</i>
by: Maan T. Khayat, et al.
Published: (2022-05-01)

Secnidazole Is a Promising Imidazole Mitigator of <i>Serratia marcescens</i> Virulence
by: Ahdab N. Khayyat, et al.
Published: (2021-11-01)

Green quantitative methods for linagliptin and empagliflozin in dosage forms
by: Fraihat Safwan M.
Published: (2024-04-01)

A Novel Use of Allopurinol as A Quorum-Sensing Inhibitor in <i>Pseudomonas aeruginosa</i>
by: Ahmed Al Saqr, et al.
Published: (2021-11-01)

Palpable Purpura in a Patient with Uncontrolled Type 2 Diabetes Mellitus: Possible Side Effect of Linagliptin
by: Ömercan Topaloğlu, et al.
Published: (2019-03-01)

Terazosin Interferes with Quorum Sensing and Type Three Secretion System and Diminishes the Bacterial Espionage to Mitigate the <i>Salmonella</i> Typhimurium Pathogenesis
by: Wael A. H. Hegazy, et al.
Published: (2022-03-01)

Neuroprotective Impact of Linagliptin against Cadmium-Induced Cognitive Impairment and Neuropathological Aberrations: Targeting SIRT1/Nrf2 Axis, Apoptosis, and Autophagy
by: Hany H. Arab, et al.
Published: (2023-07-01)

Not Only Antimicrobial: Metronidazole Mitigates the Virulence of <i>Proteus mirabilis</i> Isolated from Macerated Diabetic Foot Ulcer
by: Ahdab N. Khayyat, et al.
Published: (2021-07-01)

Linagliptin ameliorated cardiac fibrosis and restored cardiomyocyte structure in diabetic mice associated with the suppression of necroptosis
by: Juthi Adhikari, et al.
Published: (2023-07-01)

Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2012-06-01)

Journey from EMPA-REG to CARMELINA to EMPEROR-Preserved: Empagliflozin/linagliptin in heart failure and diabetes
by: Sharvil S Gadve, et al.
Published: (2022-01-01)

Regulatory Mechanisms between Quorum Sensing and Virulence in <i>Salmonella</i>
by: Xiaojie Zhang, et al.
Published: (2022-11-01)

SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in <i>db/db</i> Mice, a Model of Type 2 Diabetes
by: Anton I. Korbut, et al.
Published: (2020-04-01)

Pharmacokinetics of a Fixed-Dose Combination Product of Dapagliflozin and Linagliptin and Its Comparison with Co-Administration of Individual Tablets in Healthy Humans
by: Jin-Woo Park, et al.
Published: (2022-03-01)

Validated Stability Indicating and Assay Method Development of Linagliptin in Formulation by RP-HPLC Using Quality by Design
by: Anvesha V. Ganorkar, et al.
Published: (2020-06-01)

The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates Endothelial Inflammation and Microvascular Thrombosis in a Sepsis Mouse Model
by: Shen-Chih Wang, et al.
Published: (2022-03-01)

Post-marketing Study of Linagliptin: A Pilot Study
by: Gabrielle Kéfrem Alves Gomes, et al.
Published: (2019-05-01)

Linagliptin and Vitamin D3 Synergistically Rescue Testicular Steroidogenesis and Spermatogenesis in Cisplatin-Exposed Rats: The Crosstalk of Endoplasmic Reticulum Stress with NF-κB/iNOS Activation
by: Rania A. Elrashidy, et al.
Published: (2022-10-01)

Effect of Bromination on the Quorum Sensing-Inhibiting Properties of Indole-3-Carboxaldehydes in <i>Chromobacterium violaceum</i> AHL System
by: Chesley A. Kemp, et al.
Published: (2021-04-01)

Repositioning Linagliptin for the Mitigation of Cadmium-Induced Testicular Dysfunction in Rats: Targeting HMGB1/TLR4/NLRP3 Axis and Autophagy
by: Hany H. Arab, et al.
Published: (2022-07-01)

The Molecular Architecture of <i>Pseudomonas aeruginosa</i> Quorum-Sensing Inhibitors
by: Qiaoqiang Li, et al.
Published: (2022-07-01)

Bringing Antimicrobial Strategies to a New Level: The Quorum Sensing System as a Target to Control <i>Streptococcus suis</i>
by: Bingqian Xue, et al.
Published: (2022-12-01)

Critical Assessment of the Prospects of Quorum-Quenching Therapy for <i>Staphylococcus aureus</i> Infection
by: Michael Otto
Published: (2023-02-01)

A Localized Painful Rash Induced by Linagliptin in a Patient with type 2 Diabetes
by: İsmail Yıldız, et al.
Published: (2019-05-01)

Analytical quality by design based on design space in reversed-phase-high performance liquid chromatography analysis for simultaneous estimation of metformin, linagliptin and empagliflozin
by: Aya A. Marie, et al.
Published: (2022-06-01)

Importance of <i>N</i>-Acyl-Homoserine Lactone-Based Quorum Sensing and Quorum Quenching in Pathogen Control and Plant Growth Promotion
by: Anton Hartmann, et al.
Published: (2021-11-01)

Linagliptin and secoisolariciresinol diglucoside attenuate hyperlipidemia and cardiac hypertrophy induced by a high-methionine diet in rats via suppression of hyperhomocysteinemia-induced endoplasmic reticulum stress
by: Israa A. Jalal, et al.
Published: (2023-11-01)

Quorum Sensing and Quorum Quenching with a Focus on Cariogenic and Periodontopathic Oral Biofilms
by: Patricia P. Wright, et al.
Published: (2022-09-01)

Plasma Nitrate Levels Are Related to Metabolic Syndrome and Are Not Altered by Treatment with DPP-4 Inhibitor Linagliptin: A Randomised, Placebo-Controlled Trial in Patients with Early Type 2 Diabetes Mellitus
by: Melanie Reijrink, et al.
Published: (2021-09-01)

Antagonism of Quorum Sensing Phenotypes by Analogs of the Marine Bacterial Secondary Metabolite 3-Methyl-<i>N</i>-(2′-Phenylethyl)-Butyramide
by: Susan M. Meschwitz, et al.
Published: (2019-07-01)

Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study
by: Ahmed Fayed, et al.
Published: (2023-12-01)

Clinical efficacy and safety of linagliptin in patients with diabetes type 2
by: E. V. Biryukova, et al.
Published: (2016-12-01)

Gaussia Luciferase as a Reporter for Quorum Sensing in <i>Staphylococcus aureus</i>
by: Isobel Blower, et al.
Published: (2020-08-01)

Phloretin Inhibits Quorum Sensing and Biofilm Formation in <i>Serratia marcescens</i>
by: Yueheng Qi, et al.
Published: (2023-12-01)

Thermodynamic and Computational (DFT) Study of Non-Covalent Interaction Mechanisms of Charge Transfer Complex of Linagliptin with 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) and Chloranilic acid (CHA)
by: Ahmed H. Bakheit, et al.
Published: (2022-09-01)